Peer review reports
From: RC48-ADC treatment for patients with HER2-expressing locally advanced or metastatic solid tumors: a real-world study
Original Submission |
28 Jul 2023 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
25 Sep 2023 |
Reviewed |
Reviewer Report
|
16 Oct 2023 |
Reviewed |
Reviewer Report
|
26 Oct 2023 |
Author responded |
Author comments - Lei Xia
|
Resubmission - Version 3 |
26 Oct 2023 |
Submitted |
Manuscript version 3
|
27 Oct 2023 |
Author responded |
Author comments - Lei Xia
|
Resubmission - Version 4 |
27 Oct 2023 |
Submitted |
Manuscript version 4
|
30 Oct 2023 |
Author responded |
Author comments - Lei Xia
|
Resubmission - Version 5 |
30 Oct 2023 |
Submitted |
Manuscript version 5
|
Publishing |
30 Oct 2023 |
Editorially accepted |
|
9 Nov 2023 |
Article published |
10.1186/s12885-023-11593-9
|
Learn about peer review